Back on May 28, 2010 the Commonwealth of Pennsylvania made changes to its immunization code to be effective August 1, 2011. What children in Pennsylvania will be required to have in vaccinations in order to attend school is taken directly from the code: (http://www.pacode.com/secure…)
23.83. Immunization requirements.
(a) Duties of a school director, superintendent, principal or other person in charge of a public, private, parochial or nonpublic school. Each school director, superintendent, principal, or other person in charge of a public, private, parochial or nonpublic school in this Commonwealth, including vocational schools, intermediate units, and special education and home education programs, cyber and charter schools, shall ascertain that a child has been immunized in accordance with the requirements in subsections (b), (c) and (e) prior to admission to school for the first time, under section 1303 of the Public School Code of 1949 (24 P. S. § 13-1303a) regarding immunization required; penalty.
(b) Required for attendance. The following immunizations are required as a condition of attendance at school in this Commonwealth:
(1) Diphtheria. Four or more properly-spaced doses of diphtheria toxoid, which may be administered as a single antigen vaccine or in a combination form. The fourth dose shall be administered on or after the 4th birthday.
(2) Tetanus. Four or more properly-spaced doses of tetanus toxoid, which may be administered as a single antigen vaccine or in a combination form. The fourth dose shall be administered on or after the 4th birthday.
(3) Poliomyelitis. Three or more properly spaced doses of either oral polio vaccine or enhanced activated polio vaccine, which may be administered as a single antigen vaccine, or in a combination form. If a child received any doses of inactivated polio vaccine administered prior to 1988, a fourth dose of inactivated polio vaccine is required.
(4) Measles (rubeola). Two properly-spaced doses of live attenuated measles vaccine, the first dose administered at 12 months of age or older, or a history of measles immunity proved by laboratory testing by a laboratory with the appropriate certification. Each dose of measles vaccine may be administered as a single antigen vaccine or in a combination form.
(5) German measles (rubella). One dose of live attenuated rubella vaccine, administered at 12 months of age or older or a history of rubella immunity proved by laboratory testing by a laboratory with the appropriate certification. Rubella vaccine may be administered as a single antigen vaccine or in a combination form.
(6) Mumps. Two properly-spaced doses of live attenuated mumps vaccine, administered at 12 months of age or older or a physician diagnosis of mumps disease indicated by a written record signed by the physician or the physician’s designee. Mumps vaccine may be administered as a single antigen vaccine or in a combination form.
(7) Hepatitis B. Three properly-spaced doses of hepatitis B vaccine, unless a child receives a vaccine as approved by the Food and Drug Administration for a two-dose regimen, or a history of hepatitis B immunity proved by laboratory testing. Hepatitis B vaccine may be administered as single antigen vaccine or in a combination form.
(8) Chickenpox (varicella). One of the following:
(i) Varicella vaccine. Two properly-spaced doses of varicella vaccine, the first dose administered at 12 months of age or older. Varicella vaccine may be administered as a single antigen vaccine or in a combination form.
(ii) Evidence of immunity. Evidence of immunity may be shown by one of the following:
(A) Laboratory evidence of immunity or laboratory confirmation of disease.
(B) A written statement of a history of chickenpox disease from a parent, guardian or physician.
(c) Required for entry into 7th grade. In addition to the immunizations listed in subsection (b), the following immunizations are required at any public, private, parochial or nonpublic school in this Commonwealth, including vocational schools, intermediate unit, special education and home education programs, and cyber and charter schools as a condition of entry for students entering the 7th grade; or, in an ungraded class, for students in the school year that the student is 12 years of age:
(1) Tetanus and diphtheria toxoid and acellular pertussis vaccine (TdaP). One dose if at least 5 years have elapsed since the last dose of a vaccine containing tetanus and diphtheria as required in subsection (b). TdaP may be administered as a single antigen vaccine or in a combination form.
(2) Meningococcal Conjugate Vaccine (MCV). One dose of Meningococcal Conjugate Vaccine. MCV may be administered as a single antigen vaccine or in a combination form.
(d) Child care group setting. Attendance at a child care group setting located in a public, private or vocational school, or in an intermediate unit is conditional upon the child’s satisfaction of the immunization requirements in § 27.77 (relating to immunization requirements for children in child care group settings).
(e) Prekindergarten programs, Early Intervention programs’ early childhood special education classrooms and private academic preschools. Attendance at a prekindergarten program operated by a school district, an early intervention program operated by a contractor or subcontractor including intermediate units, school districts and private vendors, or at private academic preschools is conditional upon the child’s satisfaction of the immunization requirements in § 27.77.
(f) Grace period. A vaccine dose administered within the 4-day period prior to the minimum age for the vaccination or prior to the end of the minimum interval between doses shall be considered to be a valid dose of the vaccine for purposes of this chapter. A dose administered greater than 4 days prior to minimum age or interval for a dose is invalid for purposes of this regulation and shall be repeated.
§ 23.84. Exemption from immunization.
(a) Medical exemption. Children need not be immunized if a physician or the physician’s designee provides a written statement that immunization may be detrimental to the health of the child. When the physician determines that immunization is no longer detrimental to the health of the child, the child shall be immunized according to this subchapter.
(b) Religious exemption. Children need not be immunized if the parent, guardian or emancipated child objects in writing to the immunization on religious grounds or on the basis of a strong moral or ethical conviction similar to a religious belief.
One of the apparent—and growing—issues that neither federal nor state health agencies apparently do not take into consideration—nor want to—is the ramification(s) of what happens to a child AFTER vaccination when life-threatening or life-altering adverse events or reactions occur. Shouldn’t a state or federal agency be held responsible for the damage to that child since it mandated the vaccines for attendance in school?
No! A child’s health problems then become the family’s with no recourse for either medical help, payment of medical bills, or remedial efforts to bring back the child to normal health before the vaccination.
Too many children are experiencing adverse reactions to vaccines, which is documented by the CDC’s VAERS reporting system. To report a problem resulting from vaccines, please visit the CDC’s web site at http://vaers.hhs.gov/esub/index and follow the prompts to file a report either online, by fax, or via U.S. mail.
One of the adjuvants in most vaccines is aluminum, a neurotoxin that affects the brain and central nervous system. The following vaccines commonly contain heavy aluminum loads:
DtaP (diphtheria, tetanus, and pertussis)……… 625 mcg
Hepatitis B……………………………………. 375 mcg
Hepatitis A……………………………………. 250 mcg
Hib (haemophilus influenza type B)…………. 225 mcg
PVC (pneumococcal [pneumonia] conjugate).. 125 mcg
The above would be in addition to all the other toxins that vaccines could contain, e.g., mercury (Thimerosal), formaldehyde or formalin, antibiotics, MSG, pig gelatin, and foreign species [monkey, chick, pig, and a new one: insect] DNA, which cause adverse reactions. If combination vaccines are given in one injection, one has to multiply the loads with the number of vaccines included to understand just how damaging some vaccinations can be, especially to a child who may have a mitochondrial disease proclivity that no one is aware of since some proclivities don’t manifest until ten years of age or later.
Some medical scientists now are wondering if a mitochondrial predisposition presents a conundrum: Do vaccines precipitate mitochondrial disease or does a mitochondrial disease manifest as a result of certain drugs, pharmaceuticals, or environmental factors.
After all, vaccines are pharmaceutical drugs that contain an environmental hazardous material, i.e., mercury, and a known carcinogen, formaldehyde.
For those who doubt the neurotoxicity of aluminum, the results of a study performed by scientists at the University of British Columbia, Canada, on the effects of aluminum hydroxide injections titled “Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration” was published in November 2009 in the Journal of Inorganic Biochemistry, Volume 103, Issue 11, pages 1555-1562.
Aluminum hydroxide is an adjuvant that’s used in many vaccines. In the abstract for that article, the scientists state:
Aluminum-treated mice showed significantly increased apoptosis of motor neurons and increases in reactive astrocytes and microglial proliferation within the spinal cord and cortex. Morin stain detected the presence of aluminum in the cytoplasm of motor neurons with some neurons also testing positive for the presence of hyper-phosphorylated tau protein, a pathological hallmark of various neurological diseases, including Alzheimer’s disease and frontotemporal dementia. A second series of experiments was conducted on mice injected with six doses of aluminum hydroxide. Behavioural analyses in these mice revealed significant impairments in a number of motor functions as well as diminished spatial memory capacity. The demonstrated neurotoxicity of aluminum hydroxide and its relative ubiquity as an adjuvant suggest that greater scrutiny by the scientific community is warranted.
And, in the Introduction to that paper, this appears: In spite of the long history of widespread use, the physicochemical interactions between aluminum compounds and antigens are relatively poorly understood and their underlying mechanisms remain relatively unstudied.
So why are federal and state health agencies playing ‘Russian roulette’ with children’s health mandating vaccines that contain aluminum hydroxide [e.g., DtaP, DtaP-Hep B-IPV] aluminum hydroxyphosphate sulfate [e.g., Hepatitis B], aluminum phosphate [e.g., DtaP, Hepatitis A-Hepatitis B], and aluminum potassium sulfate [e.g., DtaP, Dtap-Hib, DT] as per the United States CDC’s Vaccine Excipient & Media Summary, page E-1?